There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research ...

Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received an average rating of “Moderate Buy” from the nine ...

TD Cowen analyst Yaron Werber maintained a Hold rating on 2seventy bio (TSVT – Research Report) today. The company’s shares closed ...

CAMBRIDGE, Mass., November 04, 2024--2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held ...

Exchange Traded Concepts LLC lowered its holdings in 2seventy bio, Inc. (NASDAQ:TSVT – Free Report) by 36.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 34,816 shares of the ...

NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of 2seventy bio, ...

Short interest in 2seventy bio Inc (NASDAQ:TSVT) increased during the last reporting period, rising from 5.13M to 5.32M. This put 12.5% of the company's publicly available shares short.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Option chain shows key data for 2seventy bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for ...

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of 2seventy bio, Inc. ("2seventy bio" or the "Company")(NASDAQ:TSVT). Such investors are ...